KinetiSol® has been the subject of numerous research articles published in top peer-reviewed journals in recent years. These papers demonstrate unique capabilities of the KinetiSol® process and its benefits for amorphous solid dispersion processing. Key advantages of the KinetiSol® process are illustrated in these case studies.
WHY USE KINETISOL?
KinetiSol® Fits In-Line with Existing Manufacturing Operations
KinetiSol® is a new unit operation for pharmaceutical manufacturing; however, the operations upstream and downstream of the KinetiSol® compounder are conventional. The amorphous powder intermediate resulting from the KinetiSol® process train can be utilized as a powder for constitution, or can be further processed into any conventional oral dosage form.